“Digoxin toxicity”的搜索结果，显示 411-420 项，共有 11904 项

1. 外科 - 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to characterize the safety, dose limiting toxicities (DLTs), maximum tolerated dose (MTD), maximum administered ...

2. 烟酸过量：有哪些症状？ - 妙佑医疗国际

   心跳加快。 瘙痒。 恶心和呕吐。 腹痛。 腹泻。 痛风。 皮疹。 如果您认为自己可能用药过量，请立即就医。 由于烟 ...

3. 血液科- 临床试验- 妙佑医疗国际

   Scottsdale/Phoenix, Ariz., Jacksonville, Fla. The purpose of this study is to evaluate the safety and tolerability, identify dose-limiting toxicities (DLT) and ...

4. 广告和赞助- 妙佑医疗国际

   美国食品和药品管理局批准的处方药; 与健康有关的消费品; 健身产品或服务; 医疗产品或器械; 药房（零售和在线药房，VIPPS 计划仅适用于在线药房 ...

5. 乳腺专科门诊- 临床试验- 妙佑医疗国际

   ... toxicity of on-time and serial administration of MV-s-NAP in patients with metastic breast cancer. Pagination 临床研究. Go to page 11 · Go to page 22 · Go to ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to evaluate the safety and tolerability, identify dose-limiting toxicities (DLT) and the maximum tolerated dose (MTD and ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to determine the maximum tolerated dose (MTD) of AG-270 and characterize its dose-limiting toxicities (DLTs) when given daily ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Key secondary endpoints are toxicity, end-Induction response, and overall survival. ... toxicity. Patient demographics, adverse events, and comorbidities will ...

9. 神经科- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to characterize the safety, dose limiting toxicities (DLTs), maximum tolerated dose (MTD), maximum administered ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    The purpose of this study is to determine the maximum tolerated dose (MTD) of AG-270 and characterize its dose-limiting toxicities (DLTs) when given daily ...